Published in Nucleic Acids Res on February 21, 2013
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication. J Virol (2013) 0.88
Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer. J Virol (2013) 0.83
VP22 core domain from Herpes simplex virus 1 reveals a surprising structural conservation in both the Alpha- and Gammaherpesvirinae subfamilies. J Gen Virol (2015) 0.80
Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus. Int J Mol Sci (2016) 0.80
Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. J Biol Chem (2016) 0.76
Structure of the opening reading frame 49 protein encoded by Kaposi's sarcoma associated herpesvirus (KSHV). J Virol (2016) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr (2011) 39.32
The Pfam protein families database. Nucleic Acids Res (2009) 37.98
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc (2008) 16.53
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
IRF family of transcription factors as regulators of host defense. Annu Rev Immunol (2001) 8.18
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J (1998) 6.94
The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol (2008) 6.60
A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr Purif (2002) 5.72
Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem (2006) 5.05
Origins of specificity in protein-DNA recognition. Annu Rev Biochem (2010) 4.43
An atomic model of the interferon-beta enhanceosome. Cell (2007) 4.22
Part I: Cancer in Indigenous Africans--burden, distribution, and trends. Lancet Oncol (2008) 3.91
An overview of the structures of protein-DNA complexes. Genome Biol (2000) 3.90
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A (2007) 3.21
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature (1998) 2.48
Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem (2000) 2.20
Crystal structure of IRF-3 in complex with CBP. Structure (2005) 2.18
Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol (1999) 2.11
High-throughput production of human proteins for crystallization: the SGC experience. J Struct Biol (2010) 2.07
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol (2003) 2.07
The search for infectious causes of human cancers: where and why. Virology (2009) 2.04
Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J (2004) 2.01
Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol (1998) 1.99
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene (2001) 1.94
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol (2003) 1.80
Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J (1999) 1.77
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett (2011) 1.71
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell (2002) 1.64
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol (1998) 1.62
Twenty-five years of immobilized metal ion affinity chromatography: past, present and future. J Biochem Biophys Methods (2001) 1.32
Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol (2001) 1.24
Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nat Methods (2009) 1.23
Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol (2001) 1.21
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet (1998) 1.20
Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. Mol Cell (2007) 1.18
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol (2008) 1.17
Viral interferon regulatory factors. J Interferon Cytokine Res (2009) 1.07
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha. Mol Med (1998) 1.04
Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J (2009) 1.02
Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Genes Cells (2010) 1.01
Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol (2003) 1.01
Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem Biophys Res Commun (2000) 0.98
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling. Cancer Res (2005) 0.96
Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J Biol Chem (2009) 0.91
Bim nuclear translocation and inactivation by viral interferon regulatory factor. PLoS Pathog (2010) 0.89
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. J Gen Virol (2011) 0.86
Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1. J Virol (2007) 0.84
Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding. Nucleic Acids Res (2011) 0.78
Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem (2006) 5.05
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci U S A (2006) 4.45
Protein production and purification. Nat Methods (2008) 3.97
In situ proteolysis for protein crystallization and structure determination. Nat Methods (2007) 3.05
Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science (2013) 2.74
Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution. Science (2006) 2.23
Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol (2011) 2.23
Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature (2007) 2.17
The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif (2007) 2.10
The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem (2008) 1.89
The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass. Science (2004) 1.53
An efficient strategy for high-throughput expression screening of recombinant integral membrane proteins. Protein Sci (2005) 1.48
Structural basis for recognition by an in vitro evolved affibody. Proc Natl Acad Sci U S A (2003) 1.46
Displacement of the tyrosyl radical cofactor in ribonucleotide reductase obtained by single-crystal high-field EPR and 1.4-A x-ray data. Proc Natl Acad Sci U S A (2003) 1.38
Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase. Nat Struct Mol Biol (2004) 1.32
Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters. Nat Struct Mol Biol (2013) 1.31
Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nat Methods (2009) 1.23
Crystal structure of a human mitochondrial deoxyribonucleotidase. Nat Struct Biol (2002) 1.22
Molecular and structural basis for redox regulation of beta-actin. J Mol Biol (2007) 1.20
Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett (2008) 1.13
Structural and biophysical characterization of the cytoplasmic domains of human BAP29 and BAP31. PLoS One (2013) 1.09
Crystal structure of the di-iron/radical protein of ribonucleotide reductase from Corynebacterium ammoniagenes. Biochemistry (2002) 1.08
Structural insights into substrate recognition in proton-dependent oligopeptide transporters. EMBO Rep (2013) 1.08
Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods (2005) 1.04
The serine-rich domain from Crk-associated substrate (p130cas) is a four-helix bundle. J Biol Chem (2005) 1.03
Engineering membrane protein overproduction in Escherichia coli. Protein Sci (2008) 1.03
Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J (2009) 1.02
Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition. J Biol Chem (2007) 1.02
The structure of the RNA m5C methyltransferase YebU from Escherichia coli reveals a C-terminal RNA-recruiting PUA domain. J Mol Biol (2006) 1.00
The structure of human collapsin response mediator protein 2, a regulator of axonal growth. J Neurochem (2007) 0.99
Crystal structure of the acyltransferase domain of the iterative polyketide synthase in enediyne biosynthesis. J Biol Chem (2012) 0.97
Catalysis within the lipid bilayer-structure and mechanism of the MAPEG family of integral membrane proteins. Curr Opin Struct Biol (2008) 0.96
An efficient and generic strategy for producing soluble human proteins and domains in E. coli by screening construct libraries. Proteins (2006) 0.95
Efficiency of hit generation and structural characterization in fragment-based ligand discovery. Curr Opin Chem Biol (2011) 0.94
A high throughput method for the detection of metalloproteins on a microgram scale. Mol Cell Proteomics (2005) 0.94
Structural insights into the mechanisms of Mg2+ uptake, transport, and gating by CorA. Proc Natl Acad Sci U S A (2012) 0.93
Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.91
Arginine 104 is a key catalytic residue in leukotriene C4 synthase. J Biol Chem (2010) 0.91
Structure of human Rack1 protein at a resolution of 2.45 Å. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.91
Purification, crystallization and preliminary X-ray diffraction analysis of the HMG domain of Sox17 in complex with DNA. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.91
High-throughput analytical gel filtration screening of integral membrane proteins for structural studies. Biochim Biophys Acta (2013) 0.91
Crystal structure of CaiB, a type-III CoA transferase in carnitine metabolism. Biochemistry (2004) 0.91
Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site. J Biol Chem (2007) 0.91
The crystal structure of a human PP2A phosphatase activator reveals a novel fold and highly conserved cleft implicated in protein-protein interactions. J Biol Chem (2006) 0.90
X-ray structure of tRNA pseudouridine synthase TruD reveals an inserted domain with a novel fold. FEBS Lett (2004) 0.89
A prokaryotic alternative oxidase present in the bacterium Novosphingobium aromaticivorans. FEBS Lett (2003) 0.89
Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. J Mol Biol (2011) 0.89
EPR studies of the mitochondrial alternative oxidase. Evidence for a diiron carboxylate center. J Biol Chem (2002) 0.89
A simple strategy towards membrane protein purification and crystallization. Int J Biol Macromol (2006) 0.88
Structural studies of tri-functional human GART. Nucleic Acids Res (2010) 0.88
Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T. J Biol Chem (2006) 0.87
The crystal structure of the protein YhaK from Escherichia coli reveals a new subclass of redox sensitive enterobacterial bicupins. Proteins (2009) 0.87
Fragment-based ligand design of novel potent inhibitors of tankyrases. J Med Chem (2013) 0.87
The crystal structure of human cleavage and polyadenylation specific factor-5 reveals a dimeric Nudix protein with a conserved catalytic site. Proteins (2008) 0.87
The transient complex of poplar plastocyanin with cytochrome f: effects of ionic strength and pH. Biochim Biophys Acta (2004) 0.86
The structure of the PP2A regulatory subunit B56 gamma: the remaining piece of the PP2A jigsaw puzzle. Proteins (2009) 0.86
Crystal structures of human and murine deoxyribonucleotidases: insights into recognition of substrates and nucleotide analogues. Biochemistry (2007) 0.85
Structural basis for substrate specificity of the human mitochondrial deoxyribonucleotidase. Structure (2005) 0.85
The crystal structure of the bifunctional deaminase/reductase RibD of the riboflavin biosynthetic pathway in Escherichia coli: implications for the reductive mechanism. J Mol Biol (2006) 0.84
Structural basis for adenosylcobalamin activation in AdoCbl-dependent ribonucleotide reductases. ACS Chem Biol (2010) 0.84
Nucleotide-dependent formation of catalytically competent dimers from engineered monomeric ribonucleotide reductase protein R1. J Biol Chem (2005) 0.84
Optimisation of over-expression in E. coli and biophysical characterisation of human membrane protein synaptogyrin 1. PLoS One (2012) 0.83
Reaction mechanism of deoxyribonucleotidase: a theoretical study. J Phys Chem B (2005) 0.83
Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes. Nat Chem Biol (2011) 0.83
Structural and mutational studies of the carboxylate cluster in iron-free ribonucleotide reductase R2. Biochemistry (2004) 0.83
Metal-mediated crystallization of the xylose transporter XylE from Escherichia coli in three different crystal forms. J Struct Biol (2013) 0.83
A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. ACS Chem Biol (2012) 0.81
High-resolution insights into binding of unfolded polypeptides by the PPIase chaperone SlpA. FASEB J (2012) 0.81
Biomimetic production of silk-like recombinant squid sucker ring teeth proteins. Biomacromolecules (2014) 0.81
Understanding specificity in metabolic pathways--structural biology of human nucleotide metabolism. Biochem Biophys Res Commun (2010) 0.81
HF-EPR, Raman, UV/VIS light spectroscopic, and DFT studies of the ribonucleotide reductase R2 tyrosyl radical from Epstein-Barr virus. PLoS One (2011) 0.80
The crystal structure of the Dachshund domain of human SnoN reveals flexibility in the putative protein interaction surface. PLoS One (2010) 0.80
Structures of the hydrolase domain of human 10-formyltetrahydrofolate dehydrogenase and its complex with a substrate analogue. Acta Crystallogr D Biol Crystallogr (2006) 0.80
Screening for functional expression and overexpression of a family of diiron-containing interfacial membrane proteins using the univector recombination system. Protein Sci (2003) 0.80
Nanobody mediated crystallization of an archeal mechanosensitive channel. PLoS One (2013) 0.80
Colony filtration blotting for screening soluble expression in Escherichia coli. Nat Protoc (2006) 0.80
Structural and functional studies of the human phosphoribosyltransferase domain containing protein 1. FEBS J (2010) 0.79
Substrate specificity and oligomerization of human GMP synthetase. J Mol Biol (2013) 0.79
A protein carboxylate coordinated oxo-centered tri-nuclear iron complex with possible implications for ferritin mineralization. FEBS Lett (2004) 0.79
GRETA, a new multifermenter system for structural genomics and process optimization. Acta Crystallogr D Biol Crystallogr (2006) 0.79
Crystal structures of the mitochondrial deoxyribonucleotidase in complex with two specific inhibitors. Mol Pharmacol (2004) 0.78
Structures of BIR domains from human NAIP and cIAP2. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.78
Screening colonies of pooled ORFeomes (SCOOP): a rapid and efficient strategy for expression screening ORFeomes in Escherichia coli. Protein Expr Purif (2009) 0.78
Expression, purification, crystallization and preliminary diffraction studies of the tRNA pseudouridine synthase TruD from Escherichia coli. Acta Crystallogr D Biol Crystallogr (2004) 0.78
Structure of the C-terminal domain of nsp4 from feline coronavirus. Acta Crystallogr D Biol Crystallogr (2009) 0.78
Structural basis for PTPA interaction with the invariant C-terminal tail of PP2A. Biol Chem (2014) 0.77
Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase. J Lipid Res (2013) 0.77
Expression, purification, crystallization and preliminary diffraction studies of the mammalian DAG kinase homologue YegS from Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.76
Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. PLoS One (2012) 0.76
Functional properties and molecular architecture of leukotriene A4 hydrolase, a pivotal catalyst of chemotactic leukotriene formation. ScientificWorldJournal (2002) 0.76
Expression, purification, crystallization and preliminary X-ray analysis of ORF60, the small subunit (R2) of ribonucleotide reductase from Kaposi's sarcoma-associated herpesvirus (KSHV). Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.75
Crystals of the ribonucleotide reductase R2 protein from Chlamydia trachomatis obtained by heavy-atom co-crystallization. Acta Crystallogr D Biol Crystallogr (2004) 0.75
Retraction of mechanistic basis for Epstein-Barr Virus ribonucleotide-reductase small-subunit function. ACS Chem Biol (2012) 0.75
High-level expression, purification, and crystallization of recombinant rat leukotriene C(4) synthase from the yeast Pichia pastoris. Protein Expr Purif (2008) 0.75
A systematic approach to isolate mono-disperse membrane proteins - purification of zinc transporter ZntB. Protein Expr Purif (2010) 0.75